Histogen Valuation
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
Histogen seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Histogen from evaluating the firm fundamentals such as Return On Equity of -1.2, shares outstanding of 4.27 M, and Return On Asset of -0.54 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Histogen's price fluctuation is not too volatile at this time. Calculation of the real value of Histogen is based on 3 months time horizon. Increasing Histogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Histogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Histogen Stock. However, Histogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.027 | Real 0.0257 | Hype 0.03 | Naive 0.0657 |
The intrinsic value of Histogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Histogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Histogen helps investors to forecast how Histogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Histogen more accurately as focusing exclusively on Histogen's fundamentals will not take into account other important factors: About Histogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Histogen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Histogen based exclusively on its fundamental and basic technical indicators. By analyzing Histogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Histogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Histogen. We calculate exposure to Histogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Histogen's related companies.Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |